Azithromycin for oral anticoagulant USP is a macrolide greater drug indicated for the inflammation of patients with azithromycin 250 mg oral suspension to widespread infections caused by susceptible ...

Please provide your email address to receive an email when new articles are posted on . Six months of azithromycin maintenance therapy reduced the rate of respiratory exacerbations and pathogenic ...

Please provide your email address to receive an email when new articles are posted on . Long-term azithromycin treatment increased lumen radius and lumen area in patients with severe persistent asthma ...

The guideline from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) does not recommend antibiotics for prevention of COPD exacerbations. Citing decades-old data on the lack of ...

An extended course of low-dose azithromycin (multiple brands) may significantly reduce treatment failure in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (COPD) ...

May 24, 2011 (Denver, Colorado) — The addition of daily azithromycin to conventional treatment for chronic obstructive pulmonary disease (COPD) significantly helps reduce acute exacerbations ...

BOS may be the result of immunologic injury targeting both endothelial and epithelial tissues in the pulmonary system, and such immunologic damage may represent cGVHD, or can be induced and aggravated ...

Epidemiologic, laboratory, animal, and clinical studies suggest that there is an association between Chlamydia pneumoniae infection and atherogenesis. We evaluated the efficacy of one year of ...

The National Pharmaceutical Pricing Authority (NPPA) has released the revised calculation sheet for the ceiling price of azithromycin 250 mg tablet following a review order from the Department of ...

Bronchiolitis obliterans syndrome (BOS), defined as new fixed airflow obstruction that develops in the setting of active chronic GVHD (cGVHD), is a serious and ...

According to investigators, clinicians need to weigh the antimicrobial benefits of azithromycin, levofloxacin, and amoxicillin-based antibiotics against their potential cardiac risks in the ...